These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15707518)

  • 1. Resiniferatoxin for detrusor instability refractory to anticholinergics.
    Palma PC; Thiel M; Riccetto CL; Dambros M; Miyaoka R; Netto NR
    Int Braz J Urol; 2004; 30(1):53-8. PubMed ID: 15707518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of intravesical resiniferatoxin for anticholinergic treatment refractory detrusor overactivity due to nonspinal cord lesions.
    Kuo HC
    J Urol; 2003 Sep; 170(3):835-9. PubMed ID: 12913711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of intravesical resiniferatoxin in treating detrusor hyper-reflexia and external sphincter dyssynergia in patients with chronic spinal cord lesions.
    Kuo HC
    BJU Int; 2003 Oct; 92(6):597-601. PubMed ID: 14511042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of intravesical resiniferatoxin in patients with idiopathic detrusor instability suggests that involuntary detrusor contractions are triggered by C-fiber input.
    Silva C; Ribeiro MJ; Cruz F
    J Urol; 2002 Aug; 168(2):575-9. PubMed ID: 12131313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple intravesical instillation of low-dose resiniferatoxin is effective in the treatment of detrusor overactivity refractory to anticholinergics.
    Kuo HC
    BJU Int; 2005 May; 95(7):1023-7. PubMed ID: 15839924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urodynamic effects of intravesical resiniferatoxin in humans: preliminary results in stable and unstable detrusor.
    Lazzeri M; Beneforti P; Turini D
    J Urol; 1997 Dec; 158(6):2093-6. PubMed ID: 9366319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravesical resiniferatoxin for the treatment of hypersensitive disorder: a randomized placebo controlled study.
    Lazzeri M; Beneforti P; Spinelli M; Zanollo A; Barbagli G; Turini D
    J Urol; 2000 Sep; 164(3 Pt 1):676-9. PubMed ID: 10953124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study.
    Giannantoni A; Di Stasi SM; Stephen RL; Bini V; Costantini E; Porena M
    J Urol; 2004 Jul; 172(1):240-3. PubMed ID: 15201783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravesical vanilloids and neurogenic incontinence: ten years experience.
    Lazzeri M; Spinelli M; Zanollo A; Turini D
    Urol Int; 2004; 72(2):145-9. PubMed ID: 14963356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of C afferent fibers and monitoring of intravesical resiniferatoxin therapy for patients with idiopathic detrusor overactivity.
    Yokoyama T; Nozaki K; Fujita O; Nose H; Inoue M; Kumon H
    J Urol; 2004 Aug; 172(2):596-600. PubMed ID: 15247740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urodynamic effect of intravesical resiniferatoxin in patients with neurogenic detrusor overactivity of spinal origin: results of a double-blind randomized placebo-controlled trial.
    Silva C; Silva J; Ribeiro MJ; Avelino A; Cruz F
    Eur Urol; 2005 Oct; 48(4):650-5. PubMed ID: 15961217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.
    Schmid DM; Sauermann P; Werner M; Schuessler B; Blick N; Muentener M; Strebel RT; Perucchini D; Scheiner D; Schaer G; John H; Reitz A; Hauri D; Schurch B
    J Urol; 2006 Jul; 176(1):177-85. PubMed ID: 16753396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravesical resiniferatoxin for refractory detrusor hyperreflexia: a multicenter, blinded, randomized, placebo-controlled trial.
    Kim JH; Rivas DA; Shenot PJ; Green B; Kennelly M; Erickson JR; O'Leary M; Yoshimura N; Chancellor MB
    J Spinal Cord Med; 2003; 26(4):358-63. PubMed ID: 14992337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involuntary detrusor contractions: correlation of urodynamic data to clinical categories.
    Romanzi LJ; Groutz A; Heritz DM; Blaivas JG
    Neurourol Urodyn; 2001; 20(3):249-57. PubMed ID: 11385691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urodynamic approach to female urinary incontinence refractory to treatment with anticholinergics.
    Naranjo-Ortiz C; Clemente-Ramos LM; Salinas-Casado J; Méndez-Rubio S
    Arch Esp Urol; 2012 Dec; 65(10):879-86. PubMed ID: 23269334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intravesical Resiniferatoxin (RTX) on lower urinary tract symptoms, urodynamic parameters, and quality of life of patients with urodynamic increased bladder sensation.
    Apostolidis A; Gonzales GE; Fowler CJ
    Eur Urol; 2006 Dec; 50(6):1299-305. PubMed ID: 16697519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents.
    Kuo HC
    Urology; 2004 May; 63(5):868-72. PubMed ID: 15134967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The overactive bladder: review of current pharmacotherapy in adults. Part 2: treatment options in cases refractory to anticholinergics.
    Sahai A; Khan MS; Arya M; John J; Singh R; Patel HR
    Expert Opin Pharmacother; 2006 Apr; 7(5):529-38. PubMed ID: 16553568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desensitization of bladder sensory fibers by intravesical resiniferatoxin, a capsaicin analog: long-term results for the treatment of detrusor hyperreflexia.
    Silva C; Rio ME; Cruz F
    Eur Urol; 2000 Oct; 38(4):444-52. PubMed ID: 11025384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravesical capsaicin versus resiniferatoxin in patients with detrusor hyperreflexia: a prospective randomized study.
    Giannantoni A; Di Stasi SM; Stephen RL; Navarra P; Scivoletto G; Mearini E; Porena M
    J Urol; 2002 Apr; 167(4):1710-4. PubMed ID: 11912393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.